OrbusNeich Medical Group Holdings Limited (HKG:6929)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
3.620
-0.050 (-1.36%)
At close: Mar 6, 2026
Market Cap2.98B +2.6%
Revenue (ttm)1.32B +11.5%
Net Income319.29M +5.1%
EPS0.39 +5.7%
Shares Out823.81M
PE Ratio9.35
Forward PE8.81
Dividend0.10 (2.72%)
Ex-Dividend DateSep 18, 2025
Volume66,500
Average Volume80,250
Open3.560
Previous Close3.670
Day's Range3.560 - 3.660
52-Week Range3.000 - 5.710
Beta-0.83
RSI43.44
Earnings DateMar 12, 2026

About HKG:6929

OrbusNeich Medical Group Holdings Limited, an investment holding company, engages in the manufacture, trading, sale, and marketing of medical devices/instruments for the treatment of coronary and peripheral vascular diseases. The company offers semi-compliant balloons and scoring balloons for pre-dilatation and lesion preparation, stents for implantation, non-compliant balloons for post-dilatation, and specialty catheters, as well as drug coated balloon, microcatheters, guide catheter extension, dual therapy, drug eluting stents, and self-expan... [Read more]

Sector Healthcare
Founded 2001
Employees 2,025
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 6929
Full Company Profile

Financial Performance

In 2024, HKG:6929's revenue was $164.10 million, an increase of 6.65% compared to the previous year's $153.87 million. Earnings were $39.72 million, a decrease of -11.88%.

Financial numbers in USD Financial Statements